Rui Wen-bin, Chen Xiao-wen
Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Zhonghua Nan Ke Xue. 2009 Oct;15(10):956-9.
As a long-acting phosphodiesterase type 5 (PDE5) inhibitor, tadalafil is administered orally as the first line therapy for erectile dysfunction (ED). Its efficacy and safety have been confirmed by many clinical studies in the treatment of ED in general patients, elderly patients and those with diabetes mellitus or spinal cord injury or after prostate cancer surgery. With its prolonged action of 36 hours, tadalafil can not only increase the self-esteem of ED men but also improve the quality of life of both the patients and their partners.
作为一种长效5型磷酸二酯酶（PDE5）抑制剂，他达拉非口服给药，是勃起功能障碍（ED）的一线治疗药物。其疗效和安全性已在一般患者、老年患者以及患有糖尿病、脊髓损伤或前列腺癌手术后的患者等多种人群中进行的许多临床研究中得到证实。他达拉非作用时间长达36小时，不仅可以增强勃起功能障碍男性的自尊心，还能改善患者及其伴侣的生活质量。
